Mar 17, 2026
During the conference, Dexcom showcased upcoming device updates, new platform features, and future innovations designed to expand and enhance its CGM ecosystem.
Mar 16, 2026
A bill stalled in Congress and a promising clinical trial may together be the most important developments in type 1 diabetes treatment right now.
Mar 12, 2026
Results from the EVOLUTION 2 trial presented at ATTD showed 68% time in range using a fully closed-loop system—with no mealtime boluses and minimal time below range.
Feb 23, 2026
Encapsulated neonatal pig islet cells, implanted without immunosuppression in the OPF-310 trial, cut a type 1 diabetes patient’s insulin needs in half at six months, with further maturation expected.
Feb 17, 2026
We spoke with an FDA-insider about how the organization regulates diabetes tech and how recent political events have shaken up the agency.
Feb 12, 2026
MannKind’s INHALE‐1ST trial is testing an inhaled insulin, as a needle‐free option for children with type 1 diabetes with an expected FDA decision by May 29, 2026.
Nov 10, 2025
We interviewed the CEO of Breakthrough T1D about how the organization reshaped diabetes tech over the years, and its latest endeavors aimed at speeding cell therapy research to cure type 1 diabetes.
Oct 15, 2025
The move to end research into a potential type 1 diabetes cure has left many people with diabetes frustrated, reflective, and still holding on to hope.
Sep 24, 2025
We dive into the history of insulin and the breakthroughs on the horizon—from smart insulin and oral treatments to weekly long-acting shots.
